Is a complete TPEX/7754 research report available?

No complete published report is available for tpex/7754 (TPEX/7754) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/7754 (TPEX/7754)

Taipei Exchange: TPEX/7754 · TWD

NT$61.2

+1.20 (+2.0%)· Recorded snapshot

Market cap	6.2B
Revenue (ttm)	959K
Net income (ttm)	-406M
EPS (ttm)	-NT$4.24
Shares out	100.9M
Volume	399,565
Beta	-0.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 959K
Net income (ttm): -406M
EPS (ttm): -NT$4.24
Market cap: 6.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TPEX/7754 indicators

Market & fundamental data

Available fields

160

Groups with data

Currency

TWD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 5.8B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	30.64
Isin	TW0007754004
Last refreshed	2026-09-12
Market cap	TWD 6.2B
Price	TWD 61.2
Price currency	TWD
Sector	Healthcare
Sector PE	83.64
Sector PE Fwd	26.88
Sic	2834
Symbol	tpex/7754
Website	https://www.ajpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.54%
FCF yield	-5.43%
P/B ratio	14.82x
P/S ratio	6,473.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	60.38%
Gross Profit	TWD 579,000
Gross Profit Growth	23.72%
Gross Profit Growth Q	-69.11%
Gross Profit Growth3 Y	-15.97%
Net Income	TWD -406M
Net Income Growth Years	0%
Pretax Margin	-42,332.12%
ROA	-33.77
ROCE	-72.04
ROE	-87.38
ROIC	-48.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	31.41%
EPS Growth Years	2
Revenue Growth	-95.98x
Revenue Growth Q	-92.43x
Revenue Growth Qo Q	28.88x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0
Assets	TWD 690M
Cash	TWD 460.3M
Current Assets	TWD 491.5M
Current Liabilities	TWD 137.4M
Debt	TWD 46.3M
Debt Equity	TWD 0.11
Debt FCF	TWD -0.14
Equity	TWD 419M
Interest Coverage	-263.8
Liabilities	TWD 271M
Long Term Assets	TWD 198.5M
Long Term Liabilities	TWD 133.6M
Net Cash	TWD 414M
Net Cash By Market Cap	TWD 6.67
Net Cash Growth	-8.65%
Net Debt Equity	TWD -0.99
Tangible Book Value	TWD 368.9M
Tangible Book Value Per Share	TWD 3.65
WACC	2.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.58
Inventory Turnover	0.02
Net Working Capital	TWD -99.3M
Quick ratio	3.35
Working Capital	TWD 354M
Working Capital Turnover	TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	31.38%
200-day SMA	56.2
50-day SMA	57.77
50-day SMA vs 200-day SMA	50over200
All Time High	72.4
All Time High Change	-15.47%
All Time High Date	2024-06-25
All Time Low	14.05
All Time Low Change	335.59%
All Time Low Date	2025-04-09
ATR	2.61
Beta	-0.3
Beta1y	0.15
Beta2y	0.48
Ch YTD	19.53
High	62.9
High52	71.2
High52 Date	2026-07-07
High52ch	-14.04%
Low	60.1
Low52	39.2
Low52 Date	2025-11-25
Low52ch	56.12%
Ma50ch	5.94%
Price vs 200-day SMA	8.91%
RSI	60.56
RSI Monthly	63.34
RSI Weekly	60.36
Sharpe ratio	0.7x
Sortino ratio	1.52
Total Return	-2.29%
Tr YTD	20.48
Tr1m	11.68%
Tr1w	6.07%
Tr3m	4.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,804,529%
Net Borrowing	-6,069,000
Shares Insiders	2.75%
Shares Institutions	10.36%
Shares Out	100,939,039
Shares Qo Q	3.94%
Shares Yo Y	2.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -353.5M
Adjusted OCF	-351,287,000
Average Volume	352,429.3x
Bv Per Share	4.15
CAPEX	TWD -2.2M
Ch1m	11.68
Ch1w	6.07
Ch1y	30.35
Ch3m	4.8
Ch6m	9.68
Change	2%
Change From Open	1.83
Close	60
Days Gap	0.17
Depreciation Amortization	37,346,000
Dollar Volume	24,453,378
Earnings Date	2026-11-13
EBIT	TWD -398.1M
EBITDA	TWD -360.7M
EPS	TWD -4.24
F Score	2
FCF	TWD -337.1M
FCF EV Yield	-5.82x
FCF Per Share	TWD -3.34
Financing CF	292,215,000
Fiscal Year End	December
Founded	2,014
Investing CF	71,377,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Ma150	58.99
Ma150ch	3.75%
Ma20	57.84
Ma20ch	5.82%
Net CF	28,713,000
Next Earnings Date	2026-11-13
Open	60.1
Position In Range	39.29
Ppne	63,169,000
Price Date	2026-09-11
Ptbv Ratio	16.83
Relative Volume	1.2x
Revenue	959,000x
SBC By Revenue	1,710.95x
Share Based Comp	16,408,000
Tr6m	9.68%
Volume	399,565
Z Score	5.33

TPEX/7754 (TPEX/7754)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/7754

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/7754 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/7754

Frequently asked questions